Amate Medical: A Rising Star in China's High-End Implantable and Interventional Device Market
AMT Medical Inc.
3D-Printed Vascular Stent Technology Developer
Recently, there is another significant positive development in the track of high-end implantable and interventional devices produced in China:Beijing AMT Medical Inc. Completes Over 200 Million Yuan in Series D Financing, Post-Investment Valuation Exceeds 1.5 Billion YuanLed by Zhejiang Synergistic Life Health Fund, with participation from Henan Key Intellectual Property Fund, Global Hedge Fund and other institutions.
Notably, in addition to the successful financing, thisHolding the first Class III CO2 contrast injection product registration certificate in China, and being the only company globally to achieve fully degradable stents for both coronary and peripheral applications.The company entering clinical trials submitted an application to the Hong Kong Stock Exchange last year and received approval from the CSRC for overseas listing.Expected to officially list on the Hong Kong Stock Exchange in the second half of this year, is expected to become "the first domestically-produced pan-vascular intervention stock".
Why AMT Medical Inc.?
Hardcore technology is the confidence to win capital bets
Under the centralized procurement, the profits of traditional consumables have been compressed to the freezing point. However, innovative products with exclusive technologies that fill clinical gaps have gained a firm foothold in the fierce market competition due to their scarcity and essential demand. AMT Medical Inc. is the most representative potential target.
For a long time, the global biodegradable stent market has been firmly monopolized by giants such as Abbott and Boston Scientific using laser cutting technology, making it difficult for Chinese manufacturers to break through. However, AMT Medical Inc. has carved out a completely independent and differentiated path:
Exclusive 3D-MAP Multi-Axis Precision Printing Technology:颠覆传统减材制造，一步成型无废料，材料利用率提升数倍，更能制造传统工艺无法实现的复杂支架结构，With superior adhesion, support force, and endothelialization speed, completely bypassing core overseas patents
Self-developed PLCL Medical Biodegradable Material:Lead the national "Challenge Project",Achieving a balance between molecular-level rigidity and flexibility, with non-toxic degradation products and clear metabolism, breaking away from the dependence on imported materials at the source
AMT Medical Inc.'s product portfolio fills critical gaps in clinical needs with each product.
Starfall Rain ® Carbon Dioxide Contrast Device:Officially approved by NMPA in April 2026, it isChina's first approved Class III CO₂ contrast injection product, with no renal toxicity and no iodine allergy risk., perfectly solving the imaging challenges for high-risk patients with renal insufficiency, iodine contrast agent allergies, and hyperthyroidism. It has been sold in over 20 countries overseas and, after being approved in China, is about to welcome its first year of significant growth.
Biodegradable Stent Pipeline:The World's Only Fully Degradable Coronary and Peripheral StentsCompany enters clinical trials: Coronary stents show 0 thrombosis after 6 years of follow-up, with long-term safety reaching world-class levels; two products have entered the National Innovative Medical Device Special Approval Channel.
Survival Rules in the Midst of Industry Shake-up
Choosing the right innovative track is more important than working hard blindly!!
It is worth mentioning that, like all research and development-based medical device companies, AMT Medical Inc.'s commercialization is still in the growth stage, and it may be difficult to achieve profitability in the short term. However, its successful financing this time precisely confirms:Focusing on clinical needs and innovative tracks with exclusive barriers is the current trend in China's medical device development.
But we deeply understand that the vast majority of dealer friends are stuck at the most awkward crossroads:
✅ Traditional consumables profits have been slashed to the floor by centralized procurement, selling more but earning less, or even losing money for publicity.
✅ Want to transition to an innovative track, but plagued by information gaps, can't distinguish which are true blue oceans and which are pseudo-concepts.
✅ Can't understand the technical barriers of the product, don't know which can be profitable in the long term and which are just fleeting.
✅ When others have already made a fortune, you only hear about this track then enter the market. You can only drink the soup or even step into a pitfall.
Many innovative medical device markets worth hundreds of millions, many distributors not only fail to make early arrangements, but they may not even pay attention to the listing news. However, those who got the information earlier and chose the right products are already enjoying the high-profit dividends brought by technological barriers.
Break the Information Barrier!
This white paper helps you identify the next big hit
In order to help a wide range of medical device distributorsBreak the Industry Information Gap, Precisely Target the High-Profit Track of Innovative Medical Devices, comprehensively grasp the core opportunities in the industry's development, we have heavily crafted and launched"Breaking Boundaries, Leading the Way: White Paper on China's Medical Device Innovation in a Global Context"
This book not onlyProvided a comprehensive overview of nearly 400 innovative products globally and in China, and conducted an in-depth analysis of 72+ product benchmark cases across 16 major medical device sectors., an innovative navigation map specifically designed for medical device distributors/agents/companies.
The First White Paper on Innovative Medical Devices in the Industry
Original Price: 499 RMB
Special Promotion Event for Customer Appreciation
Only 269 yuan!!!
?Click on the image for more details?
*Advertisement
White PaperFocusing on cardiovascular intervention, surgical robots, medical imaging, tumor ablation, orthopedics, endoscopy, and novel medical materials.16 High-Growth Popular Tracks, Selected Innovative Products, Detailed from Point to SurfaceExplain the market status, technology trends, and competitive landscape to help dealers accurately grasp the market pulse.
Taking the currently most popular surgical robot as an example, the white paper not only introduces the mainstream products currently on the market, but alsoIn-depth analysis of the technical characteristics, clinical application effects, and market strategies of various brands.By comparative analysis, dealers can clearly see the strengths and weaknesses of different products, thereby making more informed choices.
Innovation White PaperDisplay of Inner Pages of the Book
In "Pseudo-Innovation”In a market environment where products are widespread, the product overview function of white papers becomes particularly important.
It not only lists 75 innovative medical device products globally and 315 innovative medical device products in China, but also fromPolicy Support, Market Prospects, Core Technology, Clinical Application, Competitive Landscape, Manufacturer Strengthfrom multiple dimensions for a comprehensive evaluation. Breaking down information barriers, reducing information asymmetry, and helping medical device distributors gain deep and thorough insights into innovative medical device products currently available on the market.
For example, in the field of cardiovascular interventionThe white paper provides a detailed comparison of heart stent products from different brands, including their materials, design, clinical outcomes, prices, and manufacturers' production line information, offering dealers an objective and comprehensive reference.。
The First White Paper on Innovative Medical Devices in the Industry
Original Price: 499 RMB
Special Promotion Event for Customer Appreciation
Only 269 RMB!!!
?Click on the image for more details?
Display of Partial Table of Contents of the White Paper
Setting the Course for the Next Decade, Seizing Strategic Market High Ground
The white paper not only analyzes the market based on the current situation but also takes a global perspective.From multiple dimensions such as industrial development, clinical application, multidisciplinary integration, the rise of domestically produced products, and cutting-edge research, in-depth analysis of the five major development trends of innovative medical devices in the next decade, such asThe application prospects of emerging technologies such as artificial intelligence, big data, and 3D printing in the medical device field, as well as the impact of social factors like population aging and the increase in chronic diseases on market demand.
At the same time, the white paper also provides an in-depth analysis of six popular细分 markets, offering interpretations of artificial intelligence in healthcare, minimally invasive interventions, regenerative medicine, digital therapeutics, intelligent rehabilitation, and medical robotics. This guides distributors to identify opportunities in niche markets, helping them focus on the present while planning for the future.
Overview of Support Policies Across China, Accurately Grasping Industry Trends
Innovative medical device support policies, from the perspective of top-level design, represent the country's supportive attitude towards the development of innovative medical devices.This has also impacted the level of support for innovative medical care from the National Health Commission and the National Healthcare Security Administration down to hospitals at all levels.From the perspective of implementation, exceptions for innovative medical devices in DRG payments and green channels for hospital entry significantly impact hospital access.
Innovation White PaperIn-depth analysis of the support policies for innovative medical devices by the state and provinces in China over the past three years,Covering everything from top-level design, financial support to market access,Help medical device distributors gain early insights into policy trends.
A comprehensive grasp of the national and provincial innovative medical device support policies serves as the compass for industry development and the crucial key to product promotion in hospitals.
In this innovation-driven new era, only those distributors who can accurately grasp policy directions, gain insights into market trends, and precisely select products will be able to remain invincible in fierce competition.
Innovation is no longer just a decorative add-on but a required course and survival skill for distributors.Let us take "Breaking Boundaries, Leading the Way" as our guide.South, setting sail in the wave of innovation, seizes the opportunity and ushers in a new era of medical device distribution!
The First White Paper on Innovative Medical Devices in the Industry
Original Price: 499 RMB
Special Promotion Event for Customer Appreciation
Only 269 RMB!!!
?Click on the image for more details?
*Advertisement